Developer docs
API playgroundTry for free, no card

Search company profiles

Savsu Technologies

Full company profile

uuid0000xp1

Namestring
Savsu Technologies
Websiteurl
savsu.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Savsu Technologies is a U.S.-based hardware and software company founded in 2009 and headquartered in Albuquerque, New Mexico, operating with a headcount of 11-50 employees. The company builds integrated hardware and software solutions centered on passive thermal packaging technology for temperature-controlled life sciences logistics, including single-use and reusable parcel and bulk shippers utilizing proprietary VIP Vacuum Insulated Panels, PCM (Phase Change Material) phase-change cooling, and NanoCool active cooling systems.

The product portfolio spans four families — Single-Use Parcel, Reusable Parcel, Single-Use Bulk, and Reusable Bulk — covering clinical trial materials, commercial pharmaceutical distribution, and emergency response deployments. Savsu generates revenue through a mix of hardware sales (single-use and reusable containers), recurring rental services for reusable assets, and an e-commerce storefront for smaller orders, supported by a global direct enterprise field sales motion and a service network for rental returns and maintenance. In 2018, BioLife Solutions invested $6 million across two tranches and integrated the business into its cold chain logistics operations under the Peli BioThermal brand. In October 2025, BioLife Solutions divested the cold chain logistics subsidiary for $25.5 million, completing its transition to a pure-play cell processing company and ending the Savsu/Peli BioThermal chapter under BioLife ownership.

Short descriptiontext

Savsu Technologies, founded 2009 in Albuquerque, builds passive and active thermal packaging hardware and software for temperature-controlled life sciences logistics. Acquired by BioLife Solutions in 2018 and divested in October 2025 for $25.5 million.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAlbuquerque, United States
HQ citystring
Albuquerque
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
integrated hardware software, hardware systems integration, embedded software development, technology engineering solutions, connected device development
NAICS code1 code
  • Computer and Peripheral Equipment Manufacturing33411
SIC code2 codes
  • Special Industry Machinery (No Metalworking Machinery)3550
  • Services-Equipment Rental & Leasing, Nec7359
Product category
Integrated Hardware and Software Engineering Solutions
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Cell Processing Revenue
TypeHardware Sales
Description

BioLife Solutions generates cell processing revenue, reporting $25.4 million in Q3 2025, up 33% year-over-year, with full-year 2025 guidance of $93-94 million

biospace.com
2Thermal Packaging Products and Services
TypeHardware Sales
Description

Peli BioThermal generates revenue through sale and rental of thermal packaging products including single-use and reusable parcel and bulk shippers, with rental services for reusable containers

pelibiothermal.com
3Rental Services
TypeSubscription Recurring
Description

Provides rental services for reusable thermal packaging containers, supporting circular economy and cost-effective solutions for customers

pelibiothermal.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Savsu Technologies builds integrated, innovative hardware and software solutions, combining physical product engineering with software development to deliver cohesive technology offerings to business customers. The firm is a privately held, for-profit company founded in 2009, based in Albuquerque, New Mexico, with 11–50 employees. Capitalization is led by BioLife Solutions, a public life sciences tools company that participated as lead investor in both 2018 funding rounds totaling approximately $6 million.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 33% year-over-year revenue growth in Q3 2025
+1 more record
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Vacuum Insulated Panel Recycling Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Peli BioThermal has formed partnerships across the globe to tackle the challenge of recycling Vacuum Insulated Panels (VIPs), supporting the company's circular economy goals and sustainability initiatives for thermal packaging end-of-life solutions.

pelibiothermal.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Savsu Technologies

Integrated Hardware and Software Engineering Solutionssavsu.com

Savsu Technologies, founded 2009 in Albuquerque, builds passive and active thermal packaging hardware and software for temperature-controlled life sciences logistics. Acquired by BioLife Solutions in 2018 and divested in October 2025 for $25.5 million.

What Savsu Technologies does

Savsu Technologies is a U.S.-based hardware and software company founded in 2009 and headquartered in Albuquerque, New Mexico, operating with a headcount of 11-50 employees. The company builds integrated hardware and software solutions centered on passive thermal packaging technology for temperature-controlled life sciences logistics, including single-use and reusable parcel and bulk shippers utilizing proprietary VIP Vacuum Insulated Panels, PCM (Phase Change Material) phase-change cooling, and NanoCool active cooling systems.

The product portfolio spans four families — Single-Use Parcel, Reusable Parcel, Single-Use Bulk, and Reusable Bulk — covering clinical trial materials, commercial pharmaceutical distribution, and emergency response deployments. Savsu generates revenue through a mix of hardware sales (single-use and reusable containers), recurring rental services for reusable assets, and an e-commerce storefront for smaller orders, supported by a global direct enterprise field sales motion and a service network for rental returns and maintenance. In 2018, BioLife Solutions invested $6 million across two tranches and integrated the business into its cold chain logistics operations under the Peli BioThermal brand. In October 2025, BioLife Solutions divested the cold chain logistics subsidiary for $25.5 million, completing its transition to a pure-play cell processing company and ending the Savsu/Peli BioThermal chapter under BioLife ownership.

Savsu Technologies firmographics

Firmographics
Name
Savsu Technologies
Website
https://savsu.com
Company type
Private
Founded year
2009
Headcount range
1–10 employees
Short description
Savsu Technologies, founded 2009 in Albuquerque, builds passive and active thermal packaging hardware and software for temperature-controlled life sciences logistics. Acquired by BioLife Solutions in 2018 and divested in October 2025 for $25.5 million.
Ownership category
akta.pro rank

Where Savsu Technologies is headquartered

Location

Headquarters

HQ city
Albuquerque
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Savsu Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain

Revenue model

  1. Cell Processing Revenue: BioLife Solutions generates cell processing revenue, reporting $25.4 million in Q3 2025, up 33% year-over-year, with full-year 2025 guidance of $93-94 million
  2. Thermal Packaging Products and Services: Peli BioThermal generates revenue through sale and rental of thermal packaging products including single-use and reusable parcel and bulk shippers, with rental services for reusable containers
  3. Rental Services: Provides rental services for reusable thermal packaging containers, supporting circular economy and cost-effective solutions for customers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Savsu Technologies product offering

Product offering

Core offering

Savsu Technologies builds integrated, innovative hardware and software solutions, combining physical product engineering with software development to deliver cohesive technology offerings to business customers. The firm is a privately held, for-profit company founded in 2009, based in Albuquerque, New Mexico, with 11–50 employees. Capitalization is led by BioLife Solutions, a public life sciences tools company that participated as lead investor in both 2018 funding rounds totaling approximately $6 million.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 33% year-over-year revenue growth in Q3 2025
  • +1 more outcomes

Companies that use Savsu Technologies

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles1 record

Savsu Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Savsu Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Vacuum Insulated Panel Recycling PartnerscoreStrategic or Co-development PartnerPeli BioThermal has formed partnerships across the globe to tackle the challenge of recycling Vacuum Insulated Panels (VIPs), supporting the company's circular economy goals and sustainability initiatives for thermal packaging end-of-life solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Savsu Technologies competitors and assessment

Company assessment

Market position

Competitive moat3 records

Customer concentration

Savsu Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Savsu Technologies leadership team

Management profile

Number of profiles

Profiles1 record

Savsu Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Savsu Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Savsu Technologies

What does Savsu Technologies do?

Savsu Technologies builds integrated, innovative hardware and software solutions, combining physical product engineering with software development to deliver cohesive technology offerings to business customers. The firm is a privately held, for-profit company founded in 2009, based in Albuquerque, New Mexico, with 11–50 employees. Capitalization is led by BioLife Solutions, a public life sciences tools company that participated as lead investor in both 2018 funding rounds totaling approximately $6 million.

When was Savsu Technologies founded?

Savsu Technologies was founded in 2009. It employs 1 to 10 people.

Where is Savsu Technologies based?

Savsu Technologies is headquartered in Albuquerque, United States, in the North America region.

How does Savsu Technologies make money?

Three revenue lines are on record. Cell Processing Revenue is the primary driver. The others are thermal Packaging Products and Services and rental Services.

Does Savsu Technologies have an API?

No public API is recorded for Savsu Technologies.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioProcess InternationalBioLife eyes up M&A in ‘fragmented’ regenerative med supply spaceBioLife Solutions, a cell and gene therapy tool supplier, said it is evaluating several acquisition targets in a fragmented regenerative medicine market, with CEO Michael Rice estimating consolidation could raise its share of per-dose tool spend five to 10 times. The firm reported third-quarter 2018 biopreservation media sales of $5.3 million, up 79% year-on-year, and a $1.2 million profit. CFO Roderick de Greef said BioLife may acquire SAVSU Technologies within 15 months.PR NewswireBioLife Solutions Completes Acquisition of SAVSU TechnologiesBioLife Solutions has completed its acquisition of SAVSU Technologies through a share exchange agreement, issuing 1.1 million common shares to purchase the remaining 56% of SAVSU it did not already own. The transaction is expected to contribute approximately $500,000 in revenue for the remainder of 2019 and $4 million to $6 million in incremental revenue in 2020 pending successful completion of ongoing customer evaluations. The acquisition strengthens BioLife's position as a supplier of bioproduction tools for cell and gene therapies by adding SAVSU's evo cold chain management system to its portfolio.PR NewswireSAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene TherapiesSAVSU Technologies, a developer of advanced cold chain management tools for cell and gene therapies that BioLife Solutions is acquiring, has significantly expanded its intellectual property portfolio with new patent applications covering shock absorption technologies, enhanced insulation, and predictive analytics for their evo.is cloud application. BioLife Solutions has exercised its option to acquire the remaining 56% of SAVSU's outstanding shares in exchange for 1.1 million shares of BioLife common stock, with the acquisition expected to close within 30 days. The new innovations are designed to protect fragile cell and gene therapies from in-transit damage in the evolving "pay on cure" reimbursement environment where therapeutic failure carries significant economic consequences.PR NewswireSAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene TherapiesSAVSU Technologies has partnered with United Cargo to offer same-day airport-to-airport shipping services for time-sensitive cell and gene therapy medical shipments using SAVSU's evo cold chain management system and cloud-connected containers. BioLife Solutions, which previously announced acquiring the remaining 56% of SAVSU in exchange for 1.1 million shares of its common stock, indicated the partnership is expected to close within 30 days and positions SAVSU for significant product adoption among cell and gene therapy customers. United Cargo's LifeGuard service provides dedicated personnel, priority boarding, and access to nearly 4,500 daily flights across 339 airports operated by United Airlines and United Express.PR NewswireBioLife Solutions to Acquire SAVSU TechnologiesBioLife Solutions announced it has exercised its option to acquire the remaining 56% stake in SAVSU Technologies that it does not already own, exchanging 1.1 million shares of BioLife common stock for full ownership. The acquisition, expected to close within 45 days, will bring 23 SAVSU employees, 15 patents related to cold chain technologies, and SAVSU's cloud-connected evo precision shipping container product line into the BioLife portfolio. The transaction is expected to strengthen BioLife's position as a leading supplier in the cell and gene therapy market while providing high-margin recurring revenue streams from the rental model for SAVSU's products.PR NewswireBioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene TherapySAVSU Technologies has been selected by Novartis to supply advanced cold chain management technologies for ZOLGENSMA, a gene therapy for spinal muscular atrophy that received FDA approval on May 24, 2019. AveXis, which developed ZOLGENSMA and was acquired by Novartis in April 2018 for $8.7 billion, qualified and adopted the SAVSU evo system to enhance in-transit visibility and improve delivery quality of the therapy. BioLife Solutions, which currently owns 44% of SAVSU and holds an exclusive option to purchase all remaining shares, announced the selection and expects additional announcements regarding new SAVSU customers later this year.PR NewswireSAVSU Technologies Launches Two New evo® Smart Shipper Models to Improve Apheresis Collection Shipments and Cryopreserved Cell and Gene TherapiesSAVSU Technologies announced the launch of two new smart shipping containers, the evo ACS and evo DV7, at the Phacilitate Cell & Gene Therapy World Leaders conference in Miami on January 22, 2019. The evo ACS is a 2-8C shipper specifically designed for shipping apheresis collections for cell therapies with 15+ days of thermal autonomy, while the evo DV7 extends their dry vapor shipper product line with 7 days of autonomy in a compact form factor. The company noted early focus group customer feedback indicating strong market potential for both products.PR NewswireBioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million InvestmentBioLife Solutions announced it increased its ownership stake in SAVSU Technologies from approximately 31% to 44% with a $5 million investment, with plans to support SAVSU's scaling of operations and inventory for its evo Dry Vapor Shippers used in cell and gene therapy logistics. The investment includes an 18-month purchase option allowing BioLife to acquire the remaining 56% of SAVSU for approximately $23 million in BioLife common stock, with 75% issued at closing and 25% upon achievement of revenue milestones. CEO Mike Rice stated the option provides flexibility for a full acquisition based on SAVSU's continued revenue growth and represents BioLife's strategy to invest in companies supplying the cell and gene therapy industry.PR NewswireSAVSU Technologies Secures New Corporate Campus SpaceSAVSU Technologies, a developer and manufacturer of temperature-sensitive storage and transport containers for biologics and pharmaceuticals, has secured approximately 10,000 square feet of mixed office and industrial space at 4209 Balloon Park Road NE in Albuquerque for a new corporate campus. The new facility, expected to be ready in 90 days, will double development and testing labs, add robotic fabrication equipment, and include expanded design, customer service, and training spaces to meet accelerating demand for the evo Cold Chain 2.0 system. The company is currently hiring locally, nationally, and internationally to support its growing customer base of specialty logistics partners and regenerative medicine clients.PR NewswireSAVSU Technologies Awarded New Patent for Cold Chain Technologies Used in Cell and Gene TherapiesSAVSU Technologies announced that the USPTO has issued a notice of allowance for patent number 10,018,614 B2 covering biologic stability, delivery logistics and administration of time/temperature-sensitive materials. The patent, co-invented by SAVSU President Bruce McCormick and BioLife Solutions CEO Mike Rice, is the company's third granted patent and relates to precision thermal shipping containers under the evo brand that maintain temperatures ranging from -196°C to controlled room temperature. The company stated this grant validates its mission to improve cold chain logistics for cell and gene therapies.